Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...
Since that moment, Moderna has taken steps to pave the path to long-term growth -- from cutting costs to focusing on its vast ...
The U.S. Food and Drug Administration is considering adding the strongest safety warning available to COVID-19 vaccines, ...
The FDA has been rumored to be evaluating whether or not to place a black box warning on vaccines for COVID-19.
A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...
Pfizer (PFE) stock falls, and its COVID vaccine peers such as Moderna (MRNA) and Novavax (NVAX) also drop as the company ...
A team led by Rensselaer Polytechnic Institute (RPI) professors Georges Belfort, Ph.D. (PI), and Pankaj Karande, Ph.D. (co-PI ...
Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research ...
A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after COVID-19 mRNA vaccination, Stanford University researchers found, shedding light on a mechanism that’s fueled ...
Since he entered politics, President Donald Trump has been a regular on our end-of-year list of the most egregious and ...
BioNTech has completed its exchange offer to acquire CureVacAcquisition complements BioNTech’s capabilities and proprietary technologies in mRNA ...